Identification	O
of	O
the	O
anti-mycobacterial	B:C0360390
functional	O
properties	O
of	O
piperidinol	O
derivatives	I:C1254351
.	O

Identification	O
of	O
the	O
anti-mycobacterial	O
functional	O
properties	O
of	O
piperidinol	B:C1254351
derivatives	I:C1254351
.	O

Tuberculosis	B:C0041296
(	O
Tuberculosis	O
)	O
remains	O
a	O
major	O
global	O
health	O
threat	O
and	O
is	O
now	O
the	O
leading	O
cause	O
of	I:C0007465
death	I:C0007465
from	O
a	O
single	O
infectious	O
agent	O
worldwide	O
.	O

Tuberculosis	O
(	O
Tuberculosis	B:C0041296
)	O
remains	O
a	O
major	O
global	O
health	O
threat	O
and	O
is	O
now	O
the	O
leading	O
cause	O
of	I:C0007465
death	I:C0007465
from	O
a	O
single	O
infectious	O
agent	O
worldwide	O
.	O

Tuberculosis	O
(	O
Tuberculosis	O
)	O
remains	O
a	O
major	O
global	O
health	O
threat	O
and	O
is	O
now	O
the	O
leading	O
cause	B:C0007465
of	I:C0007465
death	I:C0007465
from	O
a	O
single	O
infectious	O
agent	O
worldwide	O
.	O

The	O
current	O
Tuberculosis	B:C0041296
drug	O
regimen	O
is	O
inadequate	O
,	O
and	O
new	O
anti-tubercular	O
agents	I:C1254351
are	O
urgently	O
required	O
to	O
be	O
able	O
to	O
successfully	O
combat	O
the	O
increasing	O
prevalence	O
of	O
drug	O
-	I:C0206525
resistant	I:C0206525
TB	I:C0206525
.	O

The	O
current	O
Tuberculosis	O
drug	B:C0013227
regimen	O
is	O
inadequate	O
,	O
and	O
new	O
anti-tubercular	O
agents	I:C1254351
are	O
urgently	O
required	O
to	O
be	O
able	O
to	O
successfully	O
combat	O
the	O
increasing	O
prevalence	O
of	O
drug	O
-	I:C0206525
resistant	I:C0206525
TB	I:C0206525
.	O

The	O
current	O
Tuberculosis	O
drug	O
regimen	B:C0040808
is	O
inadequate	O
,	O
and	O
new	O
anti-tubercular	O
agents	I:C1254351
are	O
urgently	O
required	O
to	O
be	O
able	O
to	O
successfully	O
combat	O
the	O
increasing	O
prevalence	O
of	O
drug	O
-	I:C0206525
resistant	I:C0206525
TB	I:C0206525
.	O

The	O
current	O
Tuberculosis	O
drug	O
regimen	O
is	O
inadequate	O
,	O
and	O
new	O
anti-tubercular	B:C1254351
agents	I:C1254351
are	O
urgently	O
required	O
to	O
be	O
able	O
to	O
successfully	O
combat	O
the	O
increasing	O
prevalence	O
of	O
drug	O
-	I:C0206525
resistant	I:C0206525
TB	I:C0206525
.	O

The	O
current	O
Tuberculosis	O
drug	O
regimen	O
is	O
inadequate	O
,	O
and	O
new	O
anti-tubercular	O
agents	I:C1254351
are	O
urgently	O
required	O
to	O
be	O
able	O
to	O
successfully	O
combat	O
the	O
increasing	O
prevalence	O
of	O
drug	B:C0206525
-	I:C0206525
resistant	I:C0206525
TB	I:C0206525
.	O

The	O
purpose	O
of	O
this	O
study	B:C2603343
was	O
to	O
investigate	O
a	O
piperidinol	O
compound	I:C1254351
derivative	I:C1254351
that	O
is	O
highly	O
active	O
against	O
the	O
Mycobacterium	O
tuberculosis	I:C0026926
bacillus	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
investigate	O
a	O
piperidinol	B:C1254351
compound	I:C1254351
derivative	I:C1254351
that	O
is	O
highly	O
active	O
against	O
the	O
Mycobacterium	O
tuberculosis	I:C0026926
bacillus	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
investigate	O
a	O
piperidinol	O
compound	I:C1254351
derivative	I:C1254351
that	O
is	O
highly	O
active	O
against	O
the	O
Mycobacterium	B:C0026926
tuberculosis	I:C0026926
bacillus	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
investigate	O
a	O
piperidinol	O
compound	I:C1254351
derivative	I:C1254351
that	O
is	O
highly	O
active	O
against	O
the	O
Mycobacterium	O
tuberculosis	I:C0026926
bacillus	B:C0004587
.	O

The	O
antibacterial	B:C0279516
properties	O
of	O
the	O
piperidinol	O
compound	I:C1254351
and	O
its	O
corresponding	O
bis-Mannich	O
base	I:C0024728
analogue	O
were	O
evaluated	O
against	O
M.	O
smegmatis	I:C0317761
and	O
Gram	O
-	I:C0018150
negative	I:C0018150
organisms	I:C0018150
.	O

The	O
antibacterial	O
properties	O
of	O
the	O
piperidinol	B:C1254351
compound	I:C1254351
and	O
its	O
corresponding	O
bis-Mannich	O
base	I:C0024728
analogue	O
were	O
evaluated	O
against	O
M.	O
smegmatis	I:C0317761
and	O
Gram	O
-	I:C0018150
negative	I:C0018150
organisms	I:C0018150
.	O

The	O
antibacterial	O
properties	O
of	O
the	O
piperidinol	O
compound	I:C1254351
and	O
its	O
corresponding	O
bis-Mannich	B:C0024728
base	I:C0024728
analogue	O
were	O
evaluated	O
against	O
M.	O
smegmatis	I:C0317761
and	O
Gram	O
-	I:C0018150
negative	I:C0018150
organisms	I:C0018150
.	O

The	O
antibacterial	O
properties	O
of	O
the	O
piperidinol	O
compound	I:C1254351
and	O
its	O
corresponding	O
bis-Mannich	O
base	I:C0024728
analogue	B:C0243071
were	O
evaluated	O
against	O
M.	O
smegmatis	I:C0317761
and	O
Gram	O
-	I:C0018150
negative	I:C0018150
organisms	I:C0018150
.	O

The	O
antibacterial	O
properties	O
of	O
the	O
piperidinol	O
compound	I:C1254351
and	O
its	O
corresponding	O
bis-Mannich	O
base	I:C0024728
analogue	O
were	O
evaluated	B:C0220825
against	O
M.	O
smegmatis	I:C0317761
and	O
Gram	O
-	I:C0018150
negative	I:C0018150
organisms	I:C0018150
.	O

The	O
antibacterial	O
properties	O
of	O
the	O
piperidinol	O
compound	I:C1254351
and	O
its	O
corresponding	O
bis-Mannich	O
base	I:C0024728
analogue	O
were	O
evaluated	O
against	O
M.	B:C0317761
smegmatis	I:C0317761
and	O
Gram	O
-	I:C0018150
negative	I:C0018150
organisms	I:C0018150
.	O

The	O
antibacterial	O
properties	O
of	O
the	O
piperidinol	O
compound	I:C1254351
and	O
its	O
corresponding	O
bis-Mannich	O
base	I:C0024728
analogue	O
were	O
evaluated	O
against	O
M.	O
smegmatis	I:C0317761
and	O
Gram	B:C0018150
-	I:C0018150
negative	I:C0018150
organisms	I:C0018150
.	O

Cytotoxicity	B:C0596402
studies	O
were	O
undertaken	O
in	O
order	O
to	O
determine	O
the	O
selectivity	O
index	I:C0918012
for	O
these	O
compounds	O
.	O

Cytotoxicity	O
studies	B:C2603343
were	O
undertaken	O
in	O
order	O
to	O
determine	O
the	O
selectivity	O
index	I:C0918012
for	O
these	O
compounds	O
.	O

Cytotoxicity	O
studies	O
were	O
undertaken	O
in	O
order	O
to	O
determine	O
the	O
selectivity	B:C0918012
index	I:C0918012
for	O
these	O
compounds	O
.	O

Cytotoxicity	O
studies	O
were	O
undertaken	O
in	O
order	O
to	O
determine	O
the	O
selectivity	O
index	I:C0918012
for	O
these	O
compounds	B:C1254351
.	O

Spontaneous	O
resistant	O
mutants	B:C0596988
of	O
M.	O
smegmatis	I:C0317761
were	O
generated	O
against	O
the	O
piperidinol	O
and	O
corresponding	O
bis-Mannich	O
base	I:C1254351
lead	I:C1254351
derivatives	I:C1254351
and	O
whole	O
genome	O
sequencing	O
employed	O
to	O
determine	O
the	O
genetic	O
modifications	I:C4277689
that	O
lead	O
to	O
selection	O
pressure	O
in	O
the	O
presence	O
of	O
these	O
compounds	O
.	O

Spontaneous	O
resistant	O
mutants	O
of	O
M.	B:C0317761
smegmatis	I:C0317761
were	O
generated	O
against	O
the	O
piperidinol	O
and	O
corresponding	O
bis-Mannich	O
base	I:C1254351
lead	I:C1254351
derivatives	I:C1254351
and	O
whole	O
genome	O
sequencing	O
employed	O
to	O
determine	O
the	O
genetic	O
modifications	I:C4277689
that	O
lead	O
to	O
selection	O
pressure	O
in	O
the	O
presence	O
of	O
these	O
compounds	O
.	O

Spontaneous	O
resistant	O
mutants	O
of	O
M.	O
smegmatis	I:C0317761
were	O
generated	O
against	O
the	O
piperidinol	B:C1254351
and	O
corresponding	O
bis-Mannich	O
base	I:C1254351
lead	I:C1254351
derivatives	I:C1254351
and	O
whole	O
genome	O
sequencing	O
employed	O
to	O
determine	O
the	O
genetic	O
modifications	I:C4277689
that	O
lead	O
to	O
selection	O
pressure	O
in	O
the	O
presence	O
of	O
these	O
compounds	O
.	O

Spontaneous	O
resistant	O
mutants	O
of	O
M.	O
smegmatis	I:C0317761
were	O
generated	O
against	O
the	O
piperidinol	O
and	O
corresponding	O
bis-Mannich	B:C1254351
base	I:C1254351
lead	I:C1254351
derivatives	I:C1254351
and	O
whole	O
genome	O
sequencing	O
employed	O
to	O
determine	O
the	O
genetic	O
modifications	I:C4277689
that	O
lead	O
to	O
selection	O
pressure	O
in	O
the	O
presence	O
of	O
these	O
compounds	O
.	O

Spontaneous	O
resistant	O
mutants	O
of	O
M.	O
smegmatis	I:C0317761
were	O
generated	O
against	O
the	O
piperidinol	O
and	O
corresponding	O
bis-Mannich	O
base	I:C1254351
lead	I:C1254351
derivatives	I:C1254351
and	O
whole	O
genome	O
sequencing	O
employed	O
to	O
determine	O
the	O
genetic	B:C4277689
modifications	I:C4277689
that	O
lead	O
to	O
selection	O
pressure	O
in	O
the	O
presence	O
of	O
these	O
compounds	O
.	O

Spontaneous	O
resistant	O
mutants	O
of	O
M.	O
smegmatis	I:C0317761
were	O
generated	O
against	O
the	O
piperidinol	O
and	O
corresponding	O
bis-Mannich	O
base	I:C1254351
lead	I:C1254351
derivatives	I:C1254351
and	O
whole	O
genome	O
sequencing	O
employed	O
to	O
determine	O
the	O
genetic	O
modifications	I:C4277689
that	O
lead	O
to	O
selection	O
pressure	O
in	O
the	O
presence	O
of	O
these	O
compounds	B:C1254351
.	O

The	O
piperidinol	B:C1254351
and	O
the	O
bis-Mannich	O
base	I:C1254351
analogue	I:C1254351
were	O
found	O
to	O
be	O
selective	O
for	O
mycobacteria	O
and	O
rapidly	O
kill	O
this	O
organism	O
with	O
a	O
cytotoxicity	O
selectivity	O
index	I:C0918012
for	O
mycobacteria	O
of	O
>	O
30	O
-	O
fold	O
.	O

The	O
piperidinol	O
and	O
the	O
bis-Mannich	B:C1254351
base	I:C1254351
analogue	I:C1254351
were	O
found	O
to	O
be	O
selective	O
for	O
mycobacteria	O
and	O
rapidly	O
kill	O
this	O
organism	O
with	O
a	O
cytotoxicity	O
selectivity	O
index	I:C0918012
for	O
mycobacteria	O
of	O
>	O
30	O
-	O
fold	O
.	O

The	O
piperidinol	O
and	O
the	O
bis-Mannich	O
base	I:C1254351
analogue	I:C1254351
were	O
found	O
to	O
be	O
selective	O
for	O
mycobacteria	B:C0026912
and	O
rapidly	O
kill	O
this	O
organism	O
with	O
a	O
cytotoxicity	O
selectivity	O
index	I:C0918012
for	O
mycobacteria	O
of	O
>	O
30	O
-	O
fold	O
.	O

The	O
piperidinol	O
and	O
the	O
bis-Mannich	O
base	I:C1254351
analogue	I:C1254351
were	O
found	O
to	O
be	O
selective	O
for	O
mycobacteria	O
and	O
rapidly	O
kill	O
this	O
organism	O
with	O
a	O
cytotoxicity	B:C0596402
selectivity	O
index	I:C0918012
for	O
mycobacteria	O
of	O
>	O
30	O
-	O
fold	O
.	O

The	O
piperidinol	O
and	O
the	O
bis-Mannich	O
base	I:C1254351
analogue	I:C1254351
were	O
found	O
to	O
be	O
selective	O
for	O
mycobacteria	O
and	O
rapidly	O
kill	O
this	O
organism	O
with	O
a	O
cytotoxicity	O
selectivity	B:C0918012
index	I:C0918012
for	O
mycobacteria	O
of	O
>	O
30	O
-	O
fold	O
.	O

The	O
piperidinol	O
and	O
the	O
bis-Mannich	O
base	I:C1254351
analogue	I:C1254351
were	O
found	O
to	O
be	O
selective	O
for	O
mycobacteria	O
and	O
rapidly	O
kill	O
this	O
organism	O
with	O
a	O
cytotoxicity	O
selectivity	O
index	I:C0918012
for	O
mycobacteria	B:C0026912
of	O
>	O
30	O
-	O
fold	O
.	O

Whole	O
genome	O
sequencing	O
of	O
M.	B:C0317761
smegmatis	I:C0317761
strains	O
resistant	O
to	O
the	O
lead	O
compounds	I:C1254351
led	O
to	O
the	O
identification	O
of	O
a	O
number	O
of	O
single	O
nucleotide	I:C0752046
polymorphisms	I:C0752046
indicating	O
multiple	O
targets	O
.	O

Whole	O
genome	O
sequencing	O
of	O
M.	O
smegmatis	I:C0317761
strains	O
resistant	O
to	O
the	O
lead	B:C1254351
compounds	I:C1254351
led	O
to	O
the	O
identification	O
of	O
a	O
number	O
of	O
single	O
nucleotide	I:C0752046
polymorphisms	I:C0752046
indicating	O
multiple	O
targets	O
.	O

Whole	O
genome	O
sequencing	O
of	O
M.	O
smegmatis	I:C0317761
strains	O
resistant	O
to	O
the	O
lead	O
compounds	I:C1254351
led	O
to	O
the	O
identification	O
of	O
a	O
number	O
of	O
single	B:C0752046
nucleotide	I:C0752046
polymorphisms	I:C0752046
indicating	O
multiple	O
targets	O
.	O

Our	O
results	O
indicate	O
that	O
the	O
piperidinol	B:C1254351
moiety	I:C1254351
represents	O
an	O
attractive	O
compound	O
class	I:C1254351
in	O
the	O
pursuit	O
of	O
novel	O
anti-tubercular	O
agents	I:C1254351
.	O

Our	O
results	O
indicate	O
that	O
the	O
piperidinol	O
moiety	I:C1254351
represents	O
an	O
attractive	O
compound	B:C1254351
class	I:C1254351
in	O
the	O
pursuit	O
of	O
novel	O
anti-tubercular	O
agents	I:C1254351
.	O

Our	O
results	O
indicate	O
that	O
the	O
piperidinol	O
moiety	I:C1254351
represents	O
an	O
attractive	O
compound	O
class	I:C1254351
in	O
the	O
pursuit	O
of	O
novel	O
anti-tubercular	B:C1254351
agents	I:C1254351
.	O

